Revvity To Hold Earnings Call on Monday, October 30, 2023
09 Ottobre 2023 - 2:00PM
Business Wire
Revvity, Inc. (NYSE: RVTY), today announced that it will release
its third quarter 2023 financial results prior to market open on
Monday, October 30, 2023. The Company will host a conference call
the same day at 8:00 a.m. ET to discuss these results. Prahlad
Singh, president and chief executive officer, and Max Krakowiak,
chief financial officer, will host the conference call.
To access the call, a live audio webcast will be available via
this registration form or on the Investors section of the Company's
website.
About Revvity
At Revvity, “impossible” is inspiration, and “can’t be done” is
a call to action. Revvity provides health science solutions,
technologies, expertise, and services that deliver complete
workflows from discovery to development, and diagnosis to cure.
Revvity is revolutionizing what’s possible in healthcare, with
specialized focus areas in translational multi-omics technologies,
biomarker identification, imaging, prediction, screening, detection
and diagnosis, informatics and more.
With 2022 revenue of more than $3 billion and over 11,000
employees, Revvity serves customers across pharmaceutical and
biotech, diagnostic labs, academia and governments. It is part of
the S&P 500 index and has customers in more than 190
countries.
Stay updated by following our Newsroom, LinkedIn, X, YouTube,
Facebook and Instagram.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231009316854/en/
Media Relations: Chet Murray (781) 462-5126
chet.murray@revvity.com Investor Relations: Steve Willoughby
steve.willoughby@revvity.com
Grafico Azioni Revvity (NYSE:RVTY)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Revvity (NYSE:RVTY)
Storico
Da Giu 2023 a Giu 2024